LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | Imatinib | 0.12 | uM | LJP6 | 2 | N17 | 72 | hr | 868 | 3673 | 3486 | 1.0535 | 1.0713 |
MDA-MB-231 | Imatinib | 0.12 | uM | LJP6 | 3 | N17 | 72 | hr | 868 | 3746 | 3486 | 1.0745 | 1.0992 |
MDA-MB-231 | JNK-9L | 0.12 | uM | LJP6 | 1 | K23 | 72 | hr | 868 | 2575 | 3486 | 0.7386 | 0.6519 |
MDA-MB-231 | JNK-9L | 0.12 | uM | LJP6 | 2 | K23 | 72 | hr | 868 | 2562 | 3486 | 0.7349 | 0.6469 |
MDA-MB-231 | JNK-9L | 0.12 | uM | LJP6 | 3 | K23 | 72 | hr | 868 | 2261 | 3486 | 0.6485 | 0.5320 |
MDA-MB-231 | JW-7-24-1 | 0.12 | uM | LJP6 | 1 | B23 | 72 | hr | 868 | 2989 | 3486 | 0.8573 | 0.8100 |
MDA-MB-231 | JW-7-24-1 | 0.12 | uM | LJP6 | 2 | B23 | 72 | hr | 868 | 2541 | 3486 | 0.7288 | 0.6389 |
MDA-MB-231 | JW-7-24-1 | 0.12 | uM | LJP6 | 3 | B23 | 72 | hr | 868 | 2662 | 3486 | 0.7635 | 0.6851 |
MDA-MB-231 | Lapatinib | 0.12 | uM | LJP6 | 1 | M23 | 72 | hr | 868 | 3325 | 3486 | 0.9537 | 0.9384 |
MDA-MB-231 | Lapatinib | 0.12 | uM | LJP6 | 2 | M23 | 72 | hr | 868 | 3381 | 3486 | 0.9698 | 0.9598 |
MDA-MB-231 | Lapatinib | 0.12 | uM | LJP6 | 3 | M23 | 72 | hr | 868 | 3276 | 3486 | 0.9397 | 0.9196 |
MDA-MB-231 | LDN-193189 | 0.12 | uM | LJP5 | 1 | G05 | 72 | hr | 868 | 3489 | 3486 | 1.0007 | 1.0010 |
MDA-MB-231 | LDN-193189 | 0.12 | uM | LJP5 | 2 | G05 | 72 | hr | 868 | 3658 | 3486 | 1.0492 | 1.0655 |
MDA-MB-231 | LDN-193189 | 0.12 | uM | LJP5 | 3 | G05 | 72 | hr | 868 | 3428 | 3486 | 0.9833 | 0.9777 |
MDA-MB-231 | Linifanib | 0.12 | uM | LJP6 | 1 | J11 | 72 | hr | 868 | 3953 | 3486 | 1.1338 | 1.1782 |
MDA-MB-231 | Linifanib | 0.12 | uM | LJP6 | 2 | J11 | 72 | hr | 868 | 3845 | 3486 | 1.1029 | 1.1370 |
MDA-MB-231 | Linifanib | 0.12 | uM | LJP6 | 3 | J11 | 72 | hr | 868 | 4210 | 3486 | 1.2076 | 1.2764 |
MDA-MB-231 | Linsitinib | 0.12 | uM | LJP5 | 1 | O23 | 72 | hr | 868 | 2536 | 3486 | 0.7274 | 0.6370 |
MDA-MB-231 | Linsitinib | 0.12 | uM | LJP5 | 2 | O23 | 72 | hr | 868 | 2840 | 3486 | 0.8146 | 0.7531 |
MDA-MB-231 | Linsitinib | 0.12 | uM | LJP5 | 3 | O23 | 72 | hr | 868 | 2889 | 3486 | 0.8287 | 0.7718 |
MDA-MB-231 | Mitoxantrone | 0.12 | uM | LJP5 | 1 | C23 | 72 | hr | 868 | 932 | 3486 | 0.2673 | 0.0244 |
MDA-MB-231 | Mitoxantrone | 0.12 | uM | LJP5 | 2 | C23 | 72 | hr | 868 | 904 | 3486 | 0.2593 | 0.0137 |
MDA-MB-231 | Mitoxantrone | 0.12 | uM | LJP5 | 3 | C23 | 72 | hr | 868 | 948 | 3486 | 0.2719 | 0.0305 |
MDA-MB-231 | Mitoxantrone | 0.12 | uM | LJP6 | 1 | C23 | 72 | hr | 868 | 889 | 3486 | 0.2550 | 0.0080 |
MDA-MB-231 | Mitoxantrone | 0.12 | uM | LJP6 | 2 | C23 | 72 | hr | 868 | 910 | 3486 | 0.2610 | 0.0160 |